1
|
Soehnlein O and Swirski FK:
Hypercholesterolemia links hematopoiesis with atherosclerosis.
Trends Endocrinol Metab. 24:129–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Hansson GK: Inflammation, atherosclerosis,
and coronary artery disease. New Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Mao JJ, Liu JT, Pang XM, et al: Nicotine
induces the expression of C-reactive protein via MAPK-dependent
signal pathway in U937 macrophages. Mol Cells. 34:457–461. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Lu PP, Liu JT, Liu N, Guo F, Ji YY and
Pang XM: Pro-inflammatory effect of fibrinogen and FDP on vascular
smooth muscle cells by IL-6, TNF-α and iNOS. Life Sci. 88:839–845.
2011.PubMed/NCBI
|
5
|
Libby P: Inflammation in atherosclerosis.
Arterioscler Thromb Vasc Biol. 32:2045–2051. 2012. View Article : Google Scholar
|
6
|
Schaeffler A, Gross P, Buettner R, et al:
Fatty acid-induced induction of Toll-like receptor-4/nuclear
factor-κB pathway in adipocytes links nutritional signalling with
innate immunity. Immunology. 126:233–245. 2009.PubMed/NCBI
|
7
|
Ishiyama J, Taguchi R, Yamamoto A and
Murakami K: Palmitic acid enhances lectin-like oxidized LDL
receptor (LOX-1) expression and promotes uptake of oxidized LDL in
macrophage cells. Atherosclerosis. 209:118–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lambertucci RH, Hirabara SM, Silveira LD,
Levada-Pires AC, Curi R and Pithon-Curi TC: Palmitate increases
superoxide production through mitochondrial electron transport
chain and NADPH oxidase activity in skeletal muscle cells. J Cell
Physiol. 216:796–804. 2008. View Article : Google Scholar
|
9
|
Shi H, Kokoeva MV, Inouye K, Tzameli I,
Yin H and Flier JS: TLR4 links innate immunity and fatty
acid-induced insulin resistance. J Clin Invest. 116:3015–3025.
2006. View
Article : Google Scholar : PubMed/NCBI
|
10
|
Moers A and Schrezenmeir J: Palmitic acid
but not stearic acid inhibits NO-production in endothelial cells.
Exp Clin Endocrinol Diabetes. 105(Suppl 2): 78–80. 2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Fujiwara R, Hayashi T, Nakai T and Miyabo
S: Diltiazem inhibits DNA synthesis and Ca2+ uptake
induced by insulin, IGF-I, and PDGF in vascular smooth muscle
cells. Cardiovasc Drugs Ther. 8:861–869. 1994.PubMed/NCBI
|
12
|
Rho MC, Lee KA, Kim SM, et al:
Sensitization of vascular smooth muscle cell to TNF-α-mediated
death in the presence of palmitate. Toxicol Appl Pharmacol.
220:311–319. 2007.
|
13
|
Guo F, Liu JT, Wang CJ and Pang XM:
Pravastatin inhibits C-reactive protein generation induced by
fibrinogen, fibrin and FDP in isolated rat vascular smooth muscle
cells. Inflamm Res. 61:127–134. 2012. View Article : Google Scholar : PubMed/NCBI
|
14
|
van Wijk JP, de Koning EJ, Castro Cabezas
M and Rabelink TJ: Rosiglitazone improves postprandial triglyceride
and free fatty acid metabolism in type 2 diabetes. Diabetes Care.
28:844–849. 2005.PubMed/NCBI
|
15
|
Devaraj S, Singh U and Jialal I: Human
C-reactive protein and the metabolic syndrome. Curr Opin Lipidol.
20:182–189. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ridker PM, Hennekens CH, Buring JE and
Rifai N: C-reactive protein and other markers of inflammation in
the prediction of cardiovascular disease in women. New Engl J Med.
342:836–843. 2000. View Article : Google Scholar : PubMed/NCBI
|
17
|
Lamon BD and Hajjar DP: Inflammation at
the molecular interface of atherogenesis: an anthropological
journey. Am J Pathol. 173:1253–1264. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Venugopal SK, Devaraj S, Yuhanna I, Shaul
P and Jialal I: Demonstration that C-reactive protein decreases
eNOS expression and bioactivity in human aortic endothelial cells.
Circulation. 106:1439–1441. 2002. View Article : Google Scholar : PubMed/NCBI
|
19
|
Verma S, Li SH, Badiwala MV, et al:
Endothelin antagonism and interleukin-6 inhibition attenuate the
proatherogenic effects of C-reactive protein. Circulation.
105:1890–1896. 2002. View Article : Google Scholar : PubMed/NCBI
|
20
|
Pasceri V, Cheng JS, Willerson JT and Yeh
ET: Modulation of C-reactive protein-mediated monocyte
chemoattractant protein-1 induction in human endothelial cells by
anti-atherosclerosis drugs. Circulation. 103:2531–2534. 2001.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Zwaka TP, Hombach V and Torzewski T:
C-reactive protein-mediated low density lipoprotein uptake by
macrophages: implications for atherosclerosis. Circulation.
103:1194–1197. 2001. View Article : Google Scholar : PubMed/NCBI
|
22
|
Gerthoffer WT: Mechanisms of vascular
smooth muscle cell migration. Circ Res. 100:607–621. 2007.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Skoog T, Dichtl W, Boquist S, et al:
Plasma tumour necrosis factor-α and early carotid atherosclerosis
in healthy middle-aged men. Eur Heart J. 23:376–383. 2002.
|
24
|
Popa C, Netea MG, van Riel PL, van der
Meer JW and Stalenhoef AF: The role of TNF-α in chronic
inflammatory conditions, intermediary metabolism, and
cardiovascular risk. J Lipid Res. 48:751–762. 2007.
|